Full BIO Protocol tokenomics breakdown: BIO token allocation, vesting schedule, supply distribution, unlock dates, and investor terms.
Key questions and answers about BIO Protocol tokenomics.
BIO Protocol token distribution allocates 3,320,000,000 BIO across 5 primary stakeholder groups:
BIO uses variable cliffs and vesting schedules that change depending on the allocation:
35% of the total supply (1,162,000,000 BIO) is unlocked at TGE, with the tokens split between Community and Public Sale.
BIO Protocol has a total supply of 3,320,000,000 BIO, of which 2,032,116,660 BIO (61.2% of total) is currently circulating.
Total length of the full BIO Protocol emission schedule is 7 years, with 46.46% released in Year 1, while the remaining 53.54% is released over the following 6 years.
31% of the BIO Protocol supply is allocated to community focused pools such as Ecosystem Incentives and Community Airdrop.
BIO Protocol revolutionizes decentralized science (DeSci) with a financial ecosystem tailored to accelerate the advancement of on-chain scientific initiatives. Central to this system is the $BIO token, which plays a pivotal role in funding research, intellectual property development, and fostering innovation in biotech through BioDAOs. With BIO Protocol’s robust auction contracts, BioDAOs can efficiently raise capital, ensuring transparent and decentralized allocations toward high-impact projects in science and medicine. The $BIO token serves as a utility token within the BIO Protocol ecosystem, enabling seamless interactions between investors, researchers, and biotech ventures. The platform’s dynamic economic model is designed to empower decentralized organizations by providing tools to launch auctions, tokenize assets, and allocate funding strategically. By integrating decentralized finance (DeFi) mechanisms with the scientific ecosystem, BIO Protocol ensures a continuous flow of capital into cutting-edge research and intellectual property creation. BIO Protocol’s market positioning is transformative, bridging the gap between traditional biotech funding methods and blockchain technology. Through its ecosystem, researchers gain access to a decentralized fundraising network, while investors engage in transparent, blockchain-driven funding processes. This innovative approach not only democratizes access to science funding but also accelerates talent flow into DeSci. BIO Protocol’s ecosystem establishes a self-sustaining model, with $BIO functioning as the backbone of this decentralized financial layer. With its commitment to innovation, efficiency, and transparency, BIO Protocol is redefining how science is funded, making DeSci a viable model for the future of biotech and research. Whether supporting intellectual property creation or bolstering talent acquisition, BIO Protocol empowers BioDAOs to shape the future of scientific discovery.